The relationship between serum total sialic acid levels and adenosine deaminase activity in obesity

Saudi Medical Journal

Volumn 27, Issue 2, 2006, Pages 170-173

  Kurtul, Naciye ^a   Akarsu, Ersin ^b   Aktaran, Sebnem ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; SIALIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MOLECULAR MECHANICS; OBESITY; PATHOGENESIS; SEX DIFFERENCE; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADENOSINE DEAMINASE; ADULT; FEMALE; HUMANS; MALE; N-ACETYLNEURAMINIC ACID; OBESITY;

EID: 33644548060     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wlodek D, Gonzales M. Decreased energy levels can cause and sustain obesity. J Theor Biol 2003; 225: 33-44.
2. Das UN. Is obesity an inflammatory condition? Nutrition 2001; 17: 953-966.
3. Traupe T, D'Uscio LV, Muenter K, Morawietz H, Vetter W, Barton M. Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin. Clin Sci Lond 2002; 103 Suppl 48: 13S-15S.
4. Hall JE. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381-394.
5. Egan BM, Greene EL, Goodfriend TL. Insulin resistance and cardiovascular disease. Am J Hypertens 2001; 14 (6 Pt 2): 116S-125S.
6. Crook MA, Miell J, Ameerally P, Lumb P, Singh N, Russell-Jones D, et al. Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in Fijians. Clin Chim Acta 2003; 331: 1-5.
7. Lindberg G, Eklund GA, Gullberg B. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991; 302: 143-146.
8. Lindberg G, Rastam L, Gullberg B, Eklund GA. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol 1992; 21: 253-257.
9. Gavella M, Lipovac V, Car A, Vucic M, Sokolic L, Rakos R. Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients. Acta Diabetol 2003; 40: 95-100.
10. Bottini E, Gerlini G, Lucarini N, Amante A, Gloria-Bottini F. Evidence of selective interaction between adenosine deaminase and acid phosphatase polymorphisms in fetuses carried by diabetic women. Hum Genet 1991; 87: 199-200.
11. Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 97-102.
12. Singh LS, Sharma R. Alloxan diabetes regulates adenosine deaminase activity in mice: tissue- and age-specific correlation. Biochem Mol Biol Int 1998; 46: 55-61.
13. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994; 76: 5-13.
14. McLane MP, Black PR, Law WR, Raymond RM. Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes 1990; 39: 62-69.
15. Rutkiewicz J, Gorski J. On the role of insulin in regulation of adenosine deaminase activity in rat tissues. FEBS Lett 1990; 271: 79-80.
16. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
17. Denny PC, Denny PA, Allerton SE. Determination of sialic acid using 2-thiobarbituric acid in the absence of hazardous sodium arsenite. Clin Chim Acta 1983; 131: 333-336.
18. Giusti G. Adenosine Deaminase. In: Bergmeyer HV, editor. Methods of enzymatic analysis. 2nd ed. New York: Academic Press; 1974. p. 1092-1099.
19. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
20. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107: E13.
21. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et. al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
22. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065.
23. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-Reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
24. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 2003; 69: 313-340.
25. Adanin S, Yalovetskiy IV, Nardulli BA, Sam AD 2nd, Jonjev ZS, Law WR. Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1324-1332.
26. Bottini E, Gloria-Bottini F. Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism 1999; 48: 949-951.
27. Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest 1999; 29: 413-425.
28. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001; 14: 1038-1045.
29. Crook M, Lumb P, Andrews V, Swaminathan R. Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals. Clin Sci Lond 1998; 95: 53-57.